Opzelura On Trac
BRANDING | WEBSITE | SOCIAL CAMPAIGN | COLLATERAL
Incyte Medical needed help creating a new patient access program to help make their vitiligo/atopic dermatitis drug, OPZELURA® (ruxolitinib) easier to obtain.
We started from the ground up by going through the long process of naming and branding the program. There were several iterations before settling on On Trac.
From there, we created websites for both patients and HCPs. Each site had its own messaging and required individualized legal review and approval. Due to the limited timeline, both sites were written and designed in under 5 days.
Once the sites were completed, we created numerous support materials and campaigns to promote the program.